Complete Filing Data
Hepion Pharmaceuticals, Inc. reported Stockholders Equity of $2.67 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Hepion Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$8.3M | -$13.2M | -$48.9M | -$42.2M | -$32.7M | -$20.4M | -$7.0M | -$9.4M | -$14.9M | -$17.0M | -$14.3M | -$5.3M |
| Operating Income Loss | -$4.2M | -$19.3M | -$48.4M | -$45.5M | -$30.4M | -$20.1M | -$7.8M | -$14.6M | -$20.6M | -$20.8M | -$14.0M | -$1.7M |
| General And Administrative Expense | $3.3M | $7.5M | $9.6M | $10.3M | $10.0M | $8.1M | $4.6M | $7.0M | $7.3M | $5.8M | $5.6M | $1.4M |
| Research And Development Expense | $445.5K | $11.8M | $35.6M | $33.3M | $20.4M | $12.0M | $3.2M | $7.6M | $13.4M | $15.0M | $8.4M | $314.2K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.3M | -$16.2M | -$49.3M | -$45.1M | -$32.7M | -$20.3M | -$7.9M | -$10.0M | -$15.0M | -$17.0M | ||
| Operating Expenses | $4.2M | $19.3M | $48.4M | $45.5M | $30.4M | $20.1M | $7.8M | $14.6M | $21.0M | $20.8M | $14.0M | |
| Net Income Loss Available To Common Stockholders Basic | -$48.9M | -$45.3M | -$32.7M | -$20.4M | -$12.5M | -$17.9M | -$13.1M | -$17.0M | -$22.2M | -$5.3M | ||
| Income Tax Expense Benefit | -$3.0M | -$409.0K | -$2.9M | $0.00 | $30.6K | -$908.7K | -$536.0K | -$1.9M | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $87.1K | $11.4K | -$90.2K | $0.00 | ||||||||
| Comprehensive Income Net Of Tax | -$8.3M | -$13.1M | -$48.9M | -$42.3M | -$32.7M | -$17.0M | -$14.3M | |||||
| Interest Expense | $9.5K | $10.2K | $8.9K | $31.2K | $555.0K | $339.2K | ||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $87.1K | $11.4K | -$90.2K | $0.00 | ||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Deferred Income Tax Liabilities Net | $0.00 | $409.0K | $409.0K | $409.0K | $409.0K | $360.7K | ||||||
| Nonoperating Income Expense | $4.2M | $3.8M | -$387.9K | -$3.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$472.5K | -$1.0M | -$6.1M | -$4.9M | -$3.9M | -$2.9M | -$10.5M | -$14.1M | -$13.3M | -$8.5M | -$19.9M | -$6.9M | -$9.3M | -$7.7M | -$6.1M | -$6.2M | -$4.9M | -$4.2M | -$1.8M | -$1.0M | -$2.0M | -$157.1K | -$4.0M | -$2.7M | -$5.8M | $2.0M | -$7.6M | -$4.5M | -$4.8M | -$3.9M | -$3.0M | -$4.8M | -$4.4M | -$3.1M | -$1.5M | -$9.3M | -$168.2K | ||
| Operating Income Loss | -$527.9K | -$1.7M | -$1.3M | -$4.5M | -$8.5M | -$5.2M | -$10.7M | -$14.2M | -$13.2M | -$8.5M | -$20.0M | -$7.3M | -$8.5M | -$6.9M | -$6.0M | -$6.2M | -$4.8M | -$4.2M | -$1.9M | -$1.7M | -$1.9M | -$3.9M | -$3.9M | -$3.9M | -$5.8M | -$5.2M | -$4.9M | -$6.0M | -$4.9M | -$4.7M | -$5.5M | -$4.8M | -$4.4M | -$3.1M | -$1.1M | -$459.0K | -$163.3K | -$180.4K | -$140.2K |
| General And Administrative Expense | $527.9K | $919.5K | $1.3M | $1.7M | $1.4M | $2.6M | $2.1M | $2.3M | $3.4M | $2.7M | $2.4M | $2.9M | $2.7M | $2.7M | $2.5M | $2.4M | $1.8M | $1.5M | $1.1M | $939.9K | $1.4M | $1.7M | $1.8M | $1.6M | $1.9M | $2.0M | $2.0M | $1.7M | $1.7M | $1.5M | $1.5M | $1.1M | $1.8M | $1.3M | $698.5K | $386.5K | $154.1K | $166.7K | $17.7K |
| Research And Development Expense | $423.3K | $22.2K | $2.8M | $7.1M | $2.5M | $8.5M | $11.9M | $9.8M | $5.7M | $15.7M | $4.3M | $5.8M | $4.2M | $3.5M | $3.8M | $3.0M | $2.6M | $846.5K | $755.7K | $518.0K | $2.2M | $2.1M | $2.3M | $4.0M | $3.3M | $2.9M | $4.3M | $3.1M | $3.2M | $4.0M | $3.8M | $2.6M | $1.8M | $384.1K | $72.5K | $9.2K | $13.6K | $122.4K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$472.5K | -$1.0M | -$6.1M | -$4.9M | -$3.9M | -$5.8M | -$10.5M | -$14.1M | -$13.3M | -$8.5M | -$19.9M | -$6.9M | -$9.3M | -$7.7M | -$6.1M | -$6.3M | -$4.8M | -$4.2M | -$1.8M | -$2.0M | -$2.0M | -$157.1K | -$4.0M | -$3.2M | -$5.8M | $2.0M | -$7.6M | -$6.4M | -$3.9M | -$3.0M | |||||||||
| Operating Expenses | $527.9K | $1.7M | $1.3M | $4.5M | $8.5M | $5.2M | $10.7M | $14.2M | $13.2M | $8.5M | $20.0M | $7.3M | $8.5M | $6.9M | $6.0M | $6.2M | $4.8M | $4.2M | $1.9M | $1.7M | $1.9M | $3.9M | $3.9M | $4.9M | |||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$9.3M | -$7.7M | -$6.1M | -$6.2M | -$4.9M | -$4.2M | -$1.8M | -$6.4M | -$2.0M | -$9.0M | -$4.0M | -$2.7M | -$5.8M | -$3.0M | -$7.4M | -$7.9M | -$1.5M | -$9.3M | -$168.2K | -$182.1K | -$140.5K | ||||||||||||||||||
| Income Tax Expense Benefit | -$3.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$62.0K | $95.6K | $0.00 | -$961.0K | -$536.0K | -$1.9M | |||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$9.00 | -$63.0K | $88.0K | -$6.3K | -$16.8K | $19.4K | -$60.4K | -$39.1K | $9.1K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax | -$472.5K | -$1.0M | -$6.1M | -$4.9M | -$4.0M | -$2.8M | -$10.5M | -$14.1M | -$13.2M | -$8.6M | -$20.0M | -$6.9M | -$9.3M | -$7.7M | -$6.1M | -$5.8M | -$4.8M | -$3.9M | -$4.8M | -$4.4M | |||||||||||||||||||
| Interest Expense | $4.3K | $2.4K | $2.4K | $2.3K | $2.3K | $3.2K | $2.2K | $2.1K | $2.5K | $2.1K | $16.2K | $0.00 | $0.00 | $15.4K | $441.8K | $98.3K | $55.5K | $231.9K | |||||||||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$9.00 | -$63.0K | $88.0K | -$6.3K | -$16.8K | $19.4K | -$60.4K | -$39.1K | $9.1K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||
| Deferred Income Tax Liabilities Net | $409.0K | $409.0K | $409.0K | $409.0K | $409.0K | $409.0K | $409.0K | $409.0K | $409.0K | $409.0K | $49.2K | $18.8K | $360.7K | $360.7K | |||||||||||||||||||||||||
| Nonoperating Income Expense | -$62.0K | $635.1K | -$2.7M | -$387.9K | -$8.9M | -$4.9K | -$1.7K | -$328.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.7M | -$1.9M | $7.3M | $49.9M | $93.0M | $40.5M | $15.6M | $1.7M | $3.7M | $1.3M | $3.4M | -$2.9M | -$140.5K |
| Cash | $13.9M | $2.8M | $6.0M | $7.4M | |||||||||
| Liabilities Current | $299.4K | $3.1M | $5.3M | $7.9M | $8.2M | $4.7M | $1.6M | $2.8M | $2.6M | $5.1M | $1.9M | $458.7K | $227.2K |
| Liabilities And Stockholders Equity | $3.1M | $1.6M | $18.1M | $60.2M | $103.6M | $48.6M | $20.6M | $8.2M | $11.3M | $13.1M | $5.4M | $2.0M | $86.7K |
| Common Stock Value | $1.2K | $14.00 | $10.00 | $381.00 | $7.6K | $3.2K | $375.00 | $25.00 | $979.00 | $3.2K | $2.2K | $1.8K | $900.00 |
| Assets | $3.1M | $1.6M | $18.1M | $60.2M | $103.6M | $48.6M | $20.6M | $8.2M | $11.3M | $13.1M | $5.4M | $2.0M | $86.7K |
| Accrued Liabilities Current | $77.5K | $23.7K | $2.4M | $4.8M | $2.5M | $659.6K | $851.2K | $661.4K | $1.0M | $820.9K | $456.7K | $207.9K | $40.0K |
| Accounts Payable Current | $167.8K | $220.2K | $2.3M | $2.7M | $2.4M | $3.7M | $491.6K | $748.4K | $1.6M | $4.3M | $1.5M | $243.9K | $3.6K |
| Retained Earnings Accumulated Deficit | -$246.1M | -$237.8M | -$224.6M | -$175.7M | -$133.5M | -$104.1M | -$83.8M | -$76.7M | -$67.0M | -$44.6M | -$27.6M | -$5.4M | -$140.5K |
| Liabilities | $402.4K | $3.5M | $10.8M | $10.4M | $10.6M | $8.1M | $5.0M | $6.2M | $7.5M | $11.8M | $1.9M | $4.9M | $227.2K |
| Assets Current | $3.1M | $1.6M | $17.5M | $56.5M | $97.5M | $42.6M | $14.4M | $3.0M | $6.1M | $7.9M | $5.2M | $2.0M | $86.7K |
| Additional Paid In Capital Common Stock | $224.0M | $224.8M | $142.9M | $97.7M | $76.7M | $69.7M | $32.2M | $17.4M | $2.5M | -$900.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.8M | $406.4K | $14.8M | $51.2M | $91.3M | $40.7M | $13.9M | $2.8M | |||||
| Property Plant And Equipment Net | $29.5K | $81.6K | $152.8K | $108.4K | $57.2K | $32.4K | $56.6K | $80.8K | $81.4K | $14.5K | |||
| Derivative Liabilities Noncurrent | $103.0K | $333.2K | $3.8M | $0.00 | $0.00 | $11.7K | $5.6K | $404.3K | $669.5K | $2.1M | $4.5M | ||
| Other Assets | $426.2K | $583.3K | $285.1K | $306.9K | $127.8K | $73.3K | $70.0K | $51.3K | $4.2K | ||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$2.0M | -$440.0K | -$415.0K | $2.3M | $140.0K | -$160.0K | $265.4K | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | $0.00 | $1.6M | $2.1M | $1.9M | $2.6M | $2.4M | $2.6M | $3.4M | $3.3M | ||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $0.00 | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | |||||
| Goodwill | $0.00 | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.4M | -$14.4M | -$36.4M | -$40.2M | $50.6M | $26.8M | $11.1M | -$3.1M | |||||
| Operating Lease Right Of Use Asset | $212.9K | $50.6K | $303.7K | $556.5K | $797.9K | ||||||||
| Operating Lease Liability Current | $115.9K | $53.6K | $266.7K | $279.8K | $266.7K | ||||||||
| Operating Lease Liability Noncurrent | $93.1K | $0.00 | $50.3K | $295.8K | $540.8K | ||||||||
| Dividends Preferred Stock | $0.00 | $5.3K | $5.4M | $8.5M | |||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $8.3K | $8.3K | -$78.8K | -$90.2K | $0.00 | ||||||||
| Business Combination Contingent Consideration Liability Current | $0.00 | $386.0K | $366.2K | $3.0M | $0.00 | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$3.1M | $5.6M | $2.8M | $2.7M | |||||||||
| Deferred Tax Liabilities Noncurrent | $896.7K | $1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.3M | $3.8M | $3.9M | $406.7K | $3.6M | $7.5M | $16.2M | $26.4M | $37.2M | $59.3M | $67.3M | $86.6M | $102.6M | $110.7M | $117.6M | $12.9M | $17.7M | $18.2M | $16.0M | $17.8M | $394.8K | $4.7M | -$752.6K | $3.1M | $5.0M | -$385.4K | $5.9M | -$3.0M | $1.3M | $5.0M | -$1.4M | $7.9M | $8.6M | $539.9K | -$7.3M | -$489.9K | -$322.6K | ||||
| Cash | $14.9M | $17.1M | $1.7M | $9.0M | $2.6M | $4.0M | |||||||||||||||||||||||||||||||||||
| Liabilities Current | $347.4K | $592.9K | $935.9K | $2.7M | $975.6K | $2.6M | $6.4M | $7.7M | $9.8M | $7.5M | $13.4M | $6.3M | $7.1M | $7.1M | $2.9M | $4.0M | $2.6M | $1.5M | $1.5M | $1.8M | $3.5M | $5.7M | $5.0M | $2.6M | $2.8M | $2.9M | $2.5M | $3.2M | $5.2M | $4.3M | $3.8M | $4.2M | $1.6M | $361.0K | $464.7K | $259.9K | $498.7K | $398.6K | |||
| Liabilities And Stockholders Equity | $3.7M | $4.5M | $6.3M | $3.7M | $6.0M | $16.0M | $25.0M | $36.5M | $49.5M | $69.7M | $83.6M | $95.9M | $111.6M | $119.8M | $123.8M | $20.4M | $24.1M | $23.3M | $21.1M | $23.3M | $7.9M | $14.4M | $8.0M | $9.4M | $14.1M | $18.4M | $11.8M | $16.1M | $8.8M | $6.7M | $10.6M | $2.9M | $9.5M | $9.0M | $1.0M | $2.6M | $8.8K | $76.0K | |||
| Common Stock Value | $1.2K | $1.2K | $959.00 | $663.00 | $547.00 | $547.00 | $384.00 | $384.00 | $381.00 | $7.6K | $7.6K | $7.6K | $7.6K | $7.6K | $7.6K | $901.00 | $901.00 | $606.00 | $345.00 | $345.00 | $2.1K | $1.6K | $1.1K | $8.5K | $7.8K | $7.6K | $6.4K | $6.3K | $5.6K | $2.7K | $2.7K | $2.2K | $2.2K | $2.2K | $2.2K | $1.8K | $900.00 | $900.00 | |||
| Assets | $3.7M | $4.5M | $6.3M | $3.7M | $6.0M | $16.0M | $25.0M | $36.5M | $49.5M | $69.7M | $83.6M | $95.9M | $111.6M | $119.8M | $123.8M | $20.4M | $24.1M | $23.3M | $21.1M | $23.3M | $7.9M | $14.4M | $8.0M | $9.4M | $14.1M | $18.4M | $11.8M | $16.1M | $8.8M | $6.7M | $10.6M | $2.9M | $9.5M | $9.0M | $1.0M | $2.6M | $8.8K | $76.0K | |||
| Accrued Liabilities Current | $55.9K | $48.5K | $166.5K | $306.0K | $375.0K | $793.8K | $2.9M | $3.1M | $6.3M | $4.8M | $4.3M | $3.6M | $2.2M | $1.7M | $817.3K | $2.4M | $1.4M | $412.8K | $308.4K | $535.2K | $657.1K | $421.4K | $920.3K | $831.3K | $1.3M | $1.3M | $910.8K | $921.2K | $765.0K | $847.4K | $598.9K | $1.0M | $302.7K | $246.5K | $244.4K | $66.7K | $33.6K | $36.0K | |||
| Accounts Payable Current | $77.2K | $172.7K | $243.3K | $186.3K | $446.5K | $1.5M | $3.0M | $4.2M | $3.2M | $2.6M | $8.9M | $2.4M | $1.8M | $3.1M | $1.7M | $1.3M | $972.4K | $850.1K | $675.5K | $282.6K | $706.6K | $2.2M | $2.1M | $1.7M | $1.5M | $1.6M | $1.6M | $2.3M | $4.4M | $3.4M | $3.2M | $3.2M | $1.3M | $114.4K | $213.3K | $187.7K | $55.5K | $28.0K | |||
| Retained Earnings Accumulated Deficit | -$245.4M | -$245.0M | -$243.9M | -$236.3M | -$231.4M | -$227.5M | -$213.6M | -$203.0M | -$189.0M | -$168.9M | -$160.3M | -$140.4M | -$127.1M | -$117.8M | -$110.2M | -$99.1M | -$92.3M | -$87.4M | -$81.3M | -$79.5M | -$78.4M | -$73.9M | -$73.7M | -$69.7M | -$65.3M | -$59.5M | -$61.6M | -$53.9M | -$49.4M | -$39.4M | -$35.5M | -$32.5M | -$22.2M | -$14.8M | -$6.9M | ||||||
| Liabilities | $415.8K | $708.5K | $2.4M | $4.1M | $2.4M | $8.5M | $8.8M | $10.1M | $12.3M | $10.4M | $16.2M | $9.2M | $9.0M | $9.0M | $6.2M | $7.5M | $5.8M | $4.5M | $4.8M | $5.3M | $7.3M | $9.7M | $8.7M | $6.3M | $9.1M | $9.3M | $12.1M | $10.2M | $11.8M | $5.5M | $5.7M | $4.2M | $1.6M | $361.0K | $464.7K | $10.0M | |||||
| Assets Current | $3.7M | $4.5M | $6.3M | $3.5M | $5.5M | $15.4M | $21.3M | $32.8M | $45.8M | $65.7M | $79.5M | $89.8M | $105.5M | $113.7M | $117.7M | $14.4M | $18.2M | $17.3M | $15.2M | $17.4M | $1.9M | $9.2M | $2.7M | $4.1M | $8.9M | $13.2M | $6.6M | $10.9M | $3.6M | $6.6M | $10.5M | $2.7M | $9.4M | $8.9M | $893.4K | $2.6M | |||||
| Additional Paid In Capital Common Stock | $247.1M | $246.1M | $234.3M | $234.2M | $233.3M | $233.3M | $230.3M | $228.1M | $227.8M | $224.5M | $226.5M | $226.0M | $225.4M | $228.0M | $226.8M | $226.0M | $110.3M | $108.9M | $104.5M | $95.8M | $95.8M | $77.3M | $77.5M | $72.1M | $71.7M | $69.2M | $67.5M | $60.1M | $58.6M | $44.6M | $27.0M | $26.8M | $17.4M | $16.4M | $12.7M | $7.4M | $2.5M | -$48.00 | -$900.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.3M | $2.9M | $4.6M | $1.5M | $2.1M | $13.1M | $19.3M | $30.5M | $43.0M | $59.1M | $71.7M | $79.2M | $98.7M | $110.1M | $115.4M | $13.7M | $17.6M | $16.0M | $14.9M | $17.1M | $1.7M | ||||||||||||||||||||
| Property Plant And Equipment Net | $0.00 | $41.1K | $60.8K | $63.7K | $83.0K | $106.0K | $131.0K | $176.2K | $162.8K | $172.4K | $45.5K | $52.7K | $48.4K | $57.6K | $64.8K | $65.6K | $37.1K | $41.7K | $46.4K | $61.6K | $67.6K | $71.6K | $80.0K | $73.8K | $71.9K | $77.3K | $82.7K | $86.6K | $62.1K | $55.6K | $15.8K | ||||||||||
| Derivative Liabilities Noncurrent | $68.4K | $115.7K | $1.5M | $1.4M | $1.5M | $4.8M | $762.00 | $3.5K | $5.5K | $30.8K | $34.4K | $15.3K | $409.00 | $8.8K | $208.4K | $1.3M | $139.0K | $274.3K | $1.6M | $1.7M | $3.9M | $2.4M | $2.1M | $1.5M | $1.9M | $4.4M | $9.7M | ||||||||||||||
| Other Assets | $377.0K | $377.0K | $364.2K | $260.1K | $488.9K | $436.1K | $654.5K | $567.5K | $652.2K | $495.2K | $420.0K | $285.1K | $290.6K | $128.3K | $128.3K | $127.9K | $140.7K | $127.4K | $127.8K | $131.5K | $139.8K | $61.3K | $63.2K | $68.4K | $68.4K | $68.4K | $51.3K | $51.3K | $51.3K | $51.3K | $51.3K | $55.5K | |||||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$770.0K | -$140.0K | -$88.4K | $48.4K | $80.0K | -$90.0K | -$325.0K | $750.0K | $810.0K | $30.0K | $30.0K | $100.0K | -$240.0K | $29.7K | $1.2M | $5.0K | |||||||||||||||||||||||||
| Business Combination Contingent Consideration Liability Noncurrent | $1.1M | $1.9M | $2.0M | $2.1M | $2.5M | $2.5M | $2.6M | $1.4M | $1.4M | $2.6M | $2.6M | $2.5M | $2.5M | $2.5M | $2.6M | $2.7M | $2.4M | $3.2M | $3.1M | $3.4M | $3.4M | $4.5M | $3.3M | $3.3M | |||||||||||||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | ||||||||||||||||||
| Goodwill | $0.00 | $0.00 | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | ||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $4.2M | -$1.7M | -$8.2M | -$12.1M | $74.7M | $2.1M | -$1.1M | ||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $118.3K | $150.7K | $182.0K | $242.5K | $0.00 | $0.00 | $100.2K | $168.8K | $236.5K | $369.2K | $436.3K | $493.7K | $614.2K | $672.8K | $724.9K | $642.4K | $683.7K | $724.1K | |||||||||||||||||||||||
| Operating Lease Liability Current | $118.0K | $154.1K | $134.0K | $112.3K | $0.00 | $0.00 | $105.6K | $176.9K | $247.3K | $285.3K | $286.0K | $211.1K | $275.3K | $274.6K | $273.1K | $191.3K | $190.6K | $190.0K | |||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $41.2K | $129.3K | $0.00 | $0.00 | $0.00 | $99.1K | $166.9K | $300.4K | $358.5K | $418.3K | $472.4K | $460.7K | $502.3K | $543.3K | |||||||||||||||||||||||||||
| Dividends Preferred Stock | $529.00 | $0.00 | $5.3K | $5.3K | $0.00 | $0.00 | $8.5K | $5.4M | $24.3K | $8.8M | |||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $8.3K | $8.3K | $8.3K | -$53.8K | -$53.8K | $9.2K | -$93.9K | -$87.7K | -$70.8K | -$90.3K | -$30.0K | $9.1K | |||||||||||||||||||||||||||||
| Business Combination Contingent Consideration Liability Current | $149.0K | $376.4K | $373.7K | $373.6K | $0.00 | $0.00 | $0.00 | $2.8M | $2.1M | $946.0K | |||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.1M | -$2.0M | -$4.2M | -$4.4M | -$4.4M | -$2.8M | |||||||||||||||||||||||||||||||||||
| Deferred Tax Liabilities Noncurrent | $360.7K | $360.7K | $360.7K | $360.7K | $360.7K | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $4.8M | $4.3M | $4.5M | -$5.1M | $82.0M | $43.1M | $18.7M | $12.5M | $24.8M | $19.9M | $12.5M | $3.1M |
| Investing Cash Flow * | -$132.1K | -$600.0K | -$14.3K | -$14.1K | -$130.4K | -$85.8K | -$51.5K | $900.00 | -$14.7K | -$502.2K | -$83.3K | -$15.8K |
| Operating Cash Flow * | -$3.3M | -$18.2M | -$40.9M | -$35.0M | -$31.2M | -$16.2M | -$7.6M | -$15.6M | -$19.2M | -$16.6M | -$9.7M | -$1.4M |
| Share Based Compensation | $20.8K | $791.6K | $1.3M | $2.6M | $4.7M | $2.4M | $66.2K | $234.5K | $1.7M | $901.9K | $2.1M | $195.2K |
| Depreciation Depletion And Amortization | $30.8K | $67.1K | $77.5K | $86.1K | $34.5K | $26.7K | $18.8K | $28.0K | $21.5K | $16.4K | $1.3K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$491.6K | -$1.9M | -$2.7M | -$917.3K | $4.5M | $1.4M | $509.2K | $82.0K | -$287.6K | -$192.0K | $564.0K | $168.6K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.4K | -$4.5M | $302.9K | $2.2M | -$1.1M | $3.0M | -$317.0K | -$897.7K | -$2.1M | $3.1M | $1.5M | |
| Payments To Acquire Property Plant And Equipment | $14.3K | $16.3K | $130.4K | $88.0K | $51.5K | $14.7K | $6.6K | $83.3K | $15.8K | |||
| Proceeds From Issuance Of Common Stock | $9.0M | $1.8M | $4.5M | $0.00 | $82.2M | $42.9M | $7.7M | $1.6M | $24.7M | $19.9M | ||
| Proceeds From Warrant Exercises | $1.8M | $0.00 | $12.0K | $2.1M | $142.6K | $85.0K | ||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $2.3K | $0.00 | $2.2K | $900.00 | |||||||
| Increase Decrease In Operating Lease Liability | -$209.0K | -$96.7K | -$263.4K | -$258.6K | -$231.9K | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $87.1K | $5.0K | -$47.1K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q1 2018 | Q3 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 | Q2 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $5.3M | $1.8M | $0.00 | -$2.0M | $82.2M | $6.8M | $946.5K | $1.6M | $1.2M | $801.1K | $2.2K | $33.4K | $100.0K | $100.0K | ||||||||
| Investing Cash Flow * | $0.00 | $0.00 | $0.00 | -$82.1K | $2.2K | -$37.8K | $900.00 | -$6.6K | -$43.8K | |||||||||||||
| Operating Cash Flow * | -$1.1M | -$3.6M | -$8.2M | -$10.1M | -$7.3M | -$4.7M | -$2.1M | -$3.6M | -$5.4M | -$5.2M | -$4.4M | -$2.8M | -$1.0M | -$110.7K | -$13.3K | |||||||
| Share Based Compensation | $20.8K | $705.8K | $1.9M | $1.5M | $957.9K | $8.2K | $17.5K | $217.4K | $391.1K | $554.5K | $501.1K | $10.9K | $112.0K | |||||||||
| Depreciation Depletion And Amortization | $30.8K | $18.0K | $22.7K | $23.1K | $21.4K | $18.1K | $7.2K | $7.2K | $6.5K | $7.3K | $8.3K | $4.6K | $4.9K | $6.0K | $8.4K | $7.1K | $5.3K | $2.7K | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.3K | -$364.3K | -$2.5M | $4.5M | $389.5K | $783.5K | $107.8K | $109.9K | -$53.4K | $114.4K | $92.6K | $247.5K | $44.9K | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $165.9K | -$2.5M | $566.6K | $76.3K | -$1.9M | $277.7K | -$46.2K | $146.0K | $14.7K | -$750.5K | $88.9K | $2.3M | -$25.8K | $69.6K | ||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $0.00 | $82.1K | $0.00 | $37.8K | $6.6K | $43.8K | |||||||||||||||
| Proceeds From Issuance Of Common Stock | $9.0M | $1.8M | $0.00 | $82.2M | $6.8M | $2.1M | $1.6M | $1.2M | $712.0K | |||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $12.0K | $85.0K | $85.0K | ||||||||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $2.2K | $900.00 | |||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$33.8K | -$53.6K | -$69.7K | $0.00 | ||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $86.7K | $18.8K | $3.2K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.88 | -$107.35 | -$616.07 | -$11.90 | -$0.47 | -$2.10 | -$6.11 | -$1.39 | -$2.41 | -$0.63 | -$1.02 | -$0.41 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 11.6M | 139.2K | 96.4K | 3.8M | 76.2M | 32.0M | 3.8M | 247.0K | 9.8M | 32.2M | 22.3M | 18.5M | 9.0M | 9.0M |
| Common Stock Shares Issued | 11.6M | 139.2K | 96.4K | 3.8M | 76.2M | 32.0M | 3.8M | 247.0K | 9.8M | 32.2M | 32.2M | 18.5M | 9.0M | |
| Common Stock Shares Authorized | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 9.7M | 2.0M | 183.9K | 27.1M | 21.8M | 12.8M | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 9.4M | 122.9K | 79.4K | 3.8M | 70.3M | 9.7M | 12.9M | 7.3M | 27.1M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 9.4M | 122.9K | 79.4K | 3.8M | 70.3M | 9.7M | 12.9M | 7.3M | 27.1M | |||||
| Earnings Per Share Basic | $-0.88 | $-107.35 | $-616.07 | $-11.90 | $-0.47 | $-2.10 | $-1.39 | $-2.04 | $-0.63 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.04 | -$0.09 | -$2.15 | -$36.21 | -$34.00 | -$28.13 | -$2.74 | -$3.68 | -$3.48 | -$2.24 | -$5.22 | -$1.82 | -$0.12 | -$0.10 | -$0.12 | -$0.69 | -$0.58 | -$0.97 | -$0.53 | -$7.48 | -$0.11 | -$44.27 | -$26.45 | -$0.27 | -$0.77 | $0.27 | -$0.12 | -$0.08 | -$0.13 | -$0.14 | -$0.11 | -$0.22 | -$0.33 | -$0.36 | -$0.07 | -$0.63 | -$0.02 | -$0.02 | -$0.02 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 11.6M | 11.6M | 9.6M | 7.0M | 5.8M | 5.5M | 3.8M | 3.8M | 3.8M | 76.2M | 76.2M | 76.2M | 76.2M | 76.2M | 76.2M | 9.0M | 9.0M | 6.1M | 3.5M | 3.5M | 20.8M | 16.3M | 10.7M | 85.0M | 78.2M | 75.7M | 63.7M | 62.8M | 55.6M | 27.3M | 27.3M | 22.3M | 22.3M | 22.3M | 22.2M | 9.0M | 9.0M | 9.0M | |
| Common Stock Shares Issued | 11.6M | 11.6M | 9.6M | 7.0M | 5.8M | 5.5M | 3.8M | 3.8M | 3.8M | 76.2M | 76.2M | 76.2M | 76.2M | 76.2M | 76.2M | 9.0M | 9.0M | 6.1M | 3.5M | 3.5M | 20.8M | 16.3M | 10.7M | 85.0M | 78.2M | 75.7M | 63.7M | 62.8M | 55.6M | 27.3M | 27.3M | 22.3M | 22.3M | 22.3M | 22.2M | 18.5M | 9.0M | 9.0M | |
| Common Stock Shares Authorized | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | 120.0M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 9.0M | 8.5M | 4.3M | 3.5M | 859.8K | 250.1K | 202.5K | 152.3K | 81.0M | 7.5M | 7.5M | 63.3M | 60.1M | 37.9M | 27.3M | 26.6M | 22.3M | 22.3M | 22.3M | 20.2M | 14.7M | 9.0M | 9.0M | 9.0M | |||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 11.6M | 11.3M | 2.8M | 134.4K | 116.0K | 101.5K | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 76.2M | 76.2M | 52.2M | 9.0M | 8.5M | 4.3M | 17.5M | 10.1M | |||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 11.6M | 11.3M | 2.8M | 134.4K | 116.0K | 101.5K | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 3.8M | 76.2M | 76.2M | 52.2M | 9.0M | 8.5M | 4.3M | 17.5M | 10.1M | |||||||||||||||||||
| Earnings Per Share Basic | $-0.04 | $-0.09 | $-2.15 | $-36.21 | $-34.00 | $-28.13 | $-2.74 | $-3.68 | $-3.48 | $-2.24 | $-5.22 | $-1.82 | $-0.12 | $-0.10 | $-0.12 | $-0.69 | $-0.58 | $-0.97 | $-0.11 | $-0.27 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $20.8K | $791.6K | $1.3M | $2.3M | $3.0M | $2.4M | $66.2K | $234.5K | $1.8M | $901.9K | $2.1M | $195.2K |
| Prepaid Expense Current | $1.2M | $1.2M | $2.7M | $5.3M | $6.1M | $1.9M | $465.7K | $135.6K | $108.1K | $491.0K | $681.2K | $164.4K |
| Fair Value Adjustment Of Warrants | $4.1M | -$5.6M | $1.3M | $0.00 | $0.00 | $6.1K | -$398.7K | -$5.3M | -$4.2M | -$3.8M | $387.9K | $3.6M |
| Stock Issued During Period Value New Issues | $868.8K | $40.00 | $5.0K | $82.2M | $42.9M | $7.7M | $2.0M | $24.7M | $19.9M | |||
| Fair Value Adjustment Of Warrants And Contingent Consideration | $415.0K | -$2.3M | -$146.1K | $558.7K | $5.1M | $5.6M | $3.8M | |||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $10.4M | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Conversion Of Stock Amount Converted1 | $1.0K | $5.0K | $11.0K | $10.0K | ||||||||
| Stock Issued During Period Value Warrants Exercised | $2.3M | $2.0M | $12.0K | $2.1M | $176.7K | $160.4K | ||||||
| Change In Fair Value Of Contingent Consideration And Derivative Financial Instruments | -$4.1M | $7.6M | -$877.6K | $415.0K | ||||||||
| Stock Issued1 | $0.00 | $5.0K | $0.00 | $500.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $20.8K | $28.6K | $28.6K | $705.8K | $318.9K | $334.0K | $537.1K | $546.6K | $634.7K | $556.6K | $1.2M | $812.0K | $957.9K | $1.4M | $4.1K | $8.2K | $17.1K | $17.1K | $17.5K | $62.9K | $152.8K | $217.4K | $391.1K | $445.0K | $10.9K | $112.0K | ||||||||||
| Prepaid Expense Current | $1.4M | $1.6M | $1.7M | $1.4M | $2.2M | $2.8M | $6.5M | $7.8M | $10.6M | $6.8M | $3.6M | $2.3M | $641.2K | $607.1K | $1.3M | $320.7K | $240.1K | $230.5K | $123.2K | $146.9K | $151.4K | $158.6K | $210.2K | $421.4K | $307.0K | $585.2K | $669.7K | $685.3K | $928.8K | $460.3K | $59.7K | $158.0K | ||||
| Fair Value Adjustment Of Warrants | $4.8M | -$1.2M | $3.9M | $0.00 | -$6.2K | $9.7K | -$195.9K | -$395.1K | -$93.9K | $1.5M | $391.2K | -$60.2K | -$735.2K | -$2.5M | $387.9K | $8.8M | ||||||||||||||||||||
| Stock Issued During Period Value New Issues | $2.1M | $868.8K | $5.0K | $82.2M | $4.5M | $6.8M | $5.8M | $150.0K | $73.7K | $1.8M | $1.3M | $56.2K | ||||||||||||||||||||||||
| Fair Value Adjustment Of Warrants And Contingent Consideration | -$747.2K | -$808.1K | -$23.8K | -$46.4K | -$69.1K | -$39.7K | $128.4K | $249.6K | $95.9K | $3.8M | $55.3K | $635.1K | $64.2K | $7.3M | -$2.7M | $60.2K | -$735.2K | |||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $672.8K | $9.8M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||
| Conversion Of Stock Amount Converted1 | $0.00 | $1.0K | $5.0K | $10.0K | $0.00 | $46.0K | $191.0K | |||||||||||||||||||||||||||||
| Stock Issued During Period Value Warrants Exercised | $2.3M | $12.0K | $2.1M | $176.7K | ||||||||||||||||||||||||||||||||
| Change In Fair Value Of Contingent Consideration And Derivative Financial Instruments | $47.3K | $698.1K | -$4.8M | $66.9K | $4.5M | $1.9M | $140.0K | $88.4K | -$48.4K | |||||||||||||||||||||||||||
| Stock Issued1 | $0.00 | $5.0K | $0.00 | $126.1K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.